Literature DB >> 34977358

Leveraging the power of mass spectrometry to unravel complex brain pathologies.

Jonas Bergquist1.   

Abstract

Entities:  

Year:  2019        PMID： 34977358      PMCID： PMC8686759          DOI： 10.1016/j.clinms.2019.08.002

Source DB:  PubMed          Journal:  Clin Mass Spectrom        ISSN： 2213-8005


× No keyword cloud information.
  24 in total

1.  Mechanistic investigation of the on-surface enzymatic digestion (oSED) protein adsorption detection method using targeted mass spectrometry.

Authors:  Torgny Undin; Andreas Dahlin; Katarina Hörnaeus; Jonas Bergquist; Sara Bergström Lind
Journal:  Analyst       Date:  2016-03-07       Impact factor: 4.616

2.  Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype.

Authors:  Andreas Warnecke; Sravani Musunuri; Marie N'diaye; Tatyana Sandalova; Adnane Achour; Jonas Bergquist; Robert A Harris
Journal:  J Neuroimmunol       Date:  2016-11-26       Impact factor: 3.478

3.  Hormone replacement therapy improves contractile function and myonuclear organization of single muscle fibres from postmenopausal monozygotic female twin pairs.

Authors:  Rizwan Qaisar; Guillaume Renaud; Yvette Hedstrom; Eija Pöllänen; Paula Ronkainen; Jaakko Kaprio; Markku Alen; Sarianna Sipilä; Konstantin Artemenko; Jonas Bergquist; Vuokko Kovanen; Lars Larsson
Journal:  J Physiol       Date:  2013-03-04       Impact factor: 5.182

4.  Establishing the proteome of normal human cerebrospinal fluid.

Authors:  Steven E Schutzer; Tao Liu; Benjamin H Natelson; Thomas E Angel; Athena A Schepmoes; Samuel O Purvine; Kim K Hixson; Mary S Lipton; David G Camp; Patricia K Coyle; Richard D Smith; Jonas Bergquist
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

Review 5.  Cerebral microdialysis for protein biomarker monitoring in the neurointensive care setting - a technical approach.

Authors:  Lars Hillered; Andreas P Dahlin; Fredrik Clausen; Jiangtao Chu; Jonas Bergquist; Klas Hjort; Per Enblad; Anders Lewén
Journal:  Front Neurol       Date:  2014-12-03       Impact factor: 4.003

6.  A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.

Authors:  Anne-Li Lind; Di Wu; Eva Freyhult; Constantin Bodolea; Titti Ekegren; Anders Larsson; Mats G Gustafsson; Lenka Katila; Jonas Bergquist; Torsten Gordh; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

7.  The proteome of perilymph in patients with vestibular schwannoma. A possibility to identify biomarkers for tumor associated hearing loss?

Authors:  Jesper Edvardsson Rasmussen; Göran Laurell; Helge Rask-Andersen; Jonas Bergquist; Per Olof Eriksson
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

8.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

9.  Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.

Authors:  Judit Füvesi; Jörg Hanrieder; Krisztina Bencsik; Cecilia Rajda; S Krisztián Kovács; László Kaizer; Sándor Beniczky; László Vécsei; Jonas Bergquist
Journal:  Int J Mol Sci       Date:  2012-06-21       Impact factor: 6.208

10.  Gray matter is targeted in first-attack multiple sclerosis.

Authors:  Steven E Schutzer; Thomas E Angel; Tao Liu; Athena A Schepmoes; Fang Xie; Jonas Bergquist; László Vécsei; Denes Zadori; David G Camp; Bart K Holland; Richard D Smith; Patricia K Coyle
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.